Paula Market
Family Medicine · Terre Haute, INNPI 1730178906
Payments from drug & device makers
Across 265 payments — averaging $14.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$975
- Novo Nordisk$580
- AstraZeneca$517
- Takeda Pharmaceuticals U.S.A., Inc.$259
- Lilly USA, LLC$257
- Boehringer Ingelheim$149
- plus $1K from 19 others
What the payments were for
- Food & beverage$3,80199%
- Education$401%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 76 | $975 |
| Novo Nordisk | 59 | $580 |
| AstraZeneca | 27 | $517 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $259 |
| Lilly USA, LLC | 18 | $257 |
| Boehringer Ingelheim | 13 | $149 |
| Novartis | 7 | $130 |
| Amgen | 7 | $117 |
| AbbVie(2 entities) | 6 | $101 |
| Merck | 7 | $94 |
| Boston Scientific | 1 | $94 |
| Bayer | 5 | $82 |
| Johnson & Johnson | 4 | $72 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $68 |
| Pfizer | 4 | $58 |
| Astellas Pharma US Inc | 3 | $50 |
| Amarin Pharma, Inc. | 3 | $47 |
| E.r. Squibb & Sons, L.L.C. | 2 | $40 |
| Avanir Pharmaceuticals, Inc. | 3 | $38 |
| Sanofi-aventis U.S. LLC | 1 | $25 |
| Eisai Inc. | 1 | $24 |
| Mylan Specialty L.p. | 1 | $20 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
| Ironshore Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$246
- VYVANSE$125
How this compares
$3,840 in reported general payments places this provider in the 80th percentile of 2,709 family medicine providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AbrysvoRsv Vacc, Pref A And Pref B/Pf | 36 | $11,241 |
| FarxigaDapagliflozin Propanediol | 14 | $8,808 |
| Aspirin-Dipyridamole ErAspirin/Dipyridamole | 11 | $2,765 |
| Duloxetine Hcl | 15 | $442 |
| Oxybutynin Chloride | 11 | $385 |
| Atorvastatin Calcium | 46 | $376 |
| Pantoprazole Sodium | 18 | $324 |
| Omeprazole | 29 | $261 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $198 |
| Alendronate Sodium | 30 | $186 |
| Meclizine Hcl | 12 | $171 |
| Simvastatin | 21 | $149 |
| Amlodipine Besylate | 20 | $146 |
| Levothyroxine Sodium | 19 | $146 |
| Carvedilol | 23 | $136 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerAbrysvo | $58 | $11,24136 claims |
| AstraZenecaFarxiga | $517 | $8,80814 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,709 family medicine providers in Indiana.
Other family medicine in Terre Haute
- Blair BrengleIndianapolis$10.6M
- Laura HelmanMishawaka$4M
- J Christopher SartoreEvansville$3.9M
- Hubert ReyesEvansville$3.2M
- David SchultzEvansville$3M
- Steven SmithIndianapolis$2.5M
- Renee Michelle GalenNewburgh$2.1M
- Eric HewittAvon$1.7M
- Alexander Dela LlanaEvansville$1.6M
- Jonathan ConditMuncie$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.